abrdn Life Sciences Investors(HQL)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
No SEC XBRL data
This company has no XBRL financial filings on file with SEC EDGAR. Common for ADRs, recent IPOs, OTC-listed names, and foreign filers that haven't filed 20-F yet.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
HQL Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for abrdn Life Sciences Investors (HQL). HQL is not currently included in 13F Pro's AI-ranked quality universe — this company has no xbrl financial filings on file with sec edgar. common for adrs, recent ipos, otc-listed names, and foreign filers that haven't filed 20-f yet. Top institutional holders of HQL by reported 13-F value include MORGAN STANLEY, Penserra Capital Management, RAYMOND JAMES FINANCIAL, based on the most recent SEC filings. HQL trades on the NYSE exchange and files with the SEC under CIK 884121. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HQL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for abrdn Life Sciences Investors directly from SEC EDGAR.
Get alerted when HQL's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for abrdn Life Sciences Investors including:
Top Institutional Holders of HQL
MORGAN STANLEY
$35.5M1,771,848 shPenserra Capital Management LLC
$16.8M838,890 shRAYMOND JAMES FINANCIAL INC
$13.8M689,134 shLPL Financial LLC
$10.3M514,161 shAllspring Global Investments Holdings, LLC
$9.1M455,124 shNEEDHAM INVESTMENT MANAGEMENT LLC
$8.9M443,041 shFLAGSHIP HARBOR ADVISORS, LLC
$8.0M400,765 shAMERIPRISE FINANCIAL INC
$3.9M195,451 shAdvisors Asset Management, Inc.
$3.4M169,812 sh180 WEALTH ADVISORS, LLC
$3.1M152,829 sh
| Fund | Value | Shares |
|---|---|---|
| MORGAN STANLEY | $35.5M | 1,771,848 |
| Penserra Capital Management LLC | $16.8M | 838,890 |
| RAYMOND JAMES FINANCIAL INC | $13.8M | 689,134 |
| LPL Financial LLC | $10.3M | 514,161 |
| Allspring Global Investments Holdings, LLC | $9.1M | 455,124 |
| NEEDHAM INVESTMENT MANAGEMENT LLC | $8.9M | 443,041 |
| FLAGSHIP HARBOR ADVISORS, LLC | $8.0M | 400,765 |
| AMERIPRISE FINANCIAL INC | $3.9M | 195,451 |
| Advisors Asset Management, Inc. | $3.4M | 169,812 |
| 180 WEALTH ADVISORS, LLC | $3.1M | 152,829 |
More Other Companies
ACV
Virtus Diversified Income & Convertible Fund
ADX
ADAMS DIVERSIFIED EQUITY FUND, INC.
AEF
abrdn Emerging Markets ex-China Fund, Inc.
AFB
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
AFCG
Advanced Flower Capital Inc.
AGD
abrdn Global Dynamic Dividend Fund
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
AOD
abrdn Total Dynamic Dividend Fund
Put HQL on your watchlist
Track score changes the day abrdn Life Sciences Investors files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HQL a good stock to buy?
13F Pro's AI-powered analysis of abrdn Life Sciences Investors (HQL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HQL are available on the HQL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HQL is classified as a small company.
Which hedge funds own HQL?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HQL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of abrdn Life Sciences Investors's investment landscape.